Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Legal & General Group Plc

Legal & General Group Plc reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 32.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,452,058 shares of the pharmacy operator's stock after selling 2,148,387 shares during the quarter. Legal & General Group Plc owned 0.52% of Walgreens Boots Alliance worth $41,538,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Swedbank AB lifted its holdings in shares of Walgreens Boots Alliance by 45.3% in the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after purchasing an additional 185,762 shares in the last quarter. Merit Financial Group LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $326,000. Assenagon Asset Management S.A. grew its position in Walgreens Boots Alliance by 2,599.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 622,703 shares of the pharmacy operator's stock worth $5,810,000 after purchasing an additional 599,637 shares during the last quarter. Orca Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $322,000. Finally, Sound Income Strategies LLC increased its stake in Walgreens Boots Alliance by 4.8% in the fourth quarter. Sound Income Strategies LLC now owns 507,213 shares of the pharmacy operator's stock valued at $4,732,000 after acquiring an additional 23,373 shares during the period. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Trading Up 0.8 %

Shares of WBA traded up $0.09 during trading hours on Friday, reaching $10.89. 7,857,996 shares of the company traded hands, compared to its average volume of 20,981,192. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company's fifty day moving average price is $10.82 and its two-hundred day moving average price is $10.12. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. During the same period in the previous year, the firm earned $1.20 EPS. The firm's revenue was up 4.1% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research report on Friday, April 11th. They set a "hold" rating on the stock. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Bank of America raised their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.